全球生物晶片市場 2026–2030

全球生物晶片市場預計在 2025 年至 2030 年間成長至 1,008.365 億美元，預測期內複合年成長率為 28.3%。

這份關於全球生物晶片市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。推動市場成長的因素包括：全球加速向精準腫瘤學轉型（需要多生物標記分析）、臨床檢測快速分散化至照護現場微流體技術，以及利用「晶片器官」平台拓展藥物研發開發平臺。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，利用整合式半導體CMOS感測器直接檢測電子生物標記訊號是未來幾年全球生物晶片市場成長的主要驅動力之一。此外，穿戴式貼片式生物晶片的實用化，例如採用微流體技術實現連續多重監測，以及利用合成適配體增強晶片穩定性的生物辨識探針，預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球生物晶片市場
• 2020年至2024年最終用戶細分市場分析
• 2020-2024年基於技術的細分市場分析
• 產品類型細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球生物晶片市場
• 地緣政治衝突對全球生物晶片市場的影響。

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 生物技術和製藥公司
• 醫院和診斷中心
• 學術研究機構
• 市場機會：依最終用戶分類

第9章 市場區隔：依技術分類

• 比較：按技術
• 微陣列
• 微流體技術
• 市場機會：依技術分類

第10章 市場區隔：依產品類型

• 比較：依產品類型
• DNA晶片
• 晶片實驗室
• 蛋白質晶片
• 其他
• 市場機會：依產品類型分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 以色列
  • 土耳其
• 南美洲
  • 巴西
  • 阿根廷
  • 智利
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Agilent Technologies Inc.
• Aline Inc.
• BD Biosciences
• Bio Rad Laboratories Inc.
• Boao Bio Group Co. Ltd.
• F. Hoffmann La Roche Ltd.
• Macrogen Inc.
• QIAGEN NV
• Revvity Inc.
• Siemens Healthineers AG
• Sony Biotechnology Inc.
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.
• Toray Industries Inc.

第16章附錄

The global biochips market is forecasted to grow by USD 100836.5 mn during 2025-2030, accelerating at a CAGR of 28.3% during the forecast period. The report on the global biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerating global shift precision oncology demanding multiplex biomarker analysis, rapid decentralization clinical testing toward point care microfluidics, pharmaceutical research and development pipeline expansion utilizing organ on chip platforms.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biochips market is segmented as below:

By End-User

• Biotech and pharma companies
• Hospitals and diagnostics centers
• Academic and research institutes

By Technology

• Microarrays
• Microfluidics

By Product Type

• DNA chip
• Lab-on-a-chip
• Protein chip
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• South America
  • Brazil
  • Argentina
  • Chile
• Rest of World (ROW)

This study identifies the integration semiconductor cmos sensors direct electronic biomarker signal detection as one of the prime reasons driving the global biochips market growth during the next few years. Also, implementation microfluidic continuous multiplex monitoring wearable patch biochips and shift toward synthetic aptamers biorecognition probes enhancing chip stability will lead to sizable demand in the market.

The report on the global biochips market covers the following areas:

• Global biochips market sizing
• Global biochips market forecast
• Global biochips market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biochips market vendors that include Abbott Laboratories, Agilent Technologies Inc., Aline Inc., Atomica Corp., BD Biosciences, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., F. Hoffmann La Roche Ltd., Illumina Inc., Macrogen Inc., Micronit BV, QIAGEN N.V., Randox Laboratories Ltd., RayBiotech Life Inc., Revvity Inc., Siemens Healthineers AG, Sony Biotechnology Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., Toray Industries Inc.. Also, the global biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biochips Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biochips Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biochips market
• 6.2 Impact of geopolitical conflicts on global biochips market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Biotech and pharma companies - Market size and forecast 2025-2030
• 8.4 Hospitals and diagnostics centers - Market size and forecast 2025-2030
• 8.5 Academic and research institutes - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Technology

• 9.1 Market segments
• 9.2 Comparison by Technology
• 9.3 Microarrays - Market size and forecast 2025-2030
• 9.4 Microfluidics - Market size and forecast 2025-2030
• 9.5 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 DNA chip - Market size and forecast 2025-2030
• 10.4 Lab-on-a-chip - Market size and forecast 2025-2030
• 10.5 Protein chip - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 APAC - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Australia - Market size and forecast 2025-2030
  • 12.4.6 Indonesia - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Middle East and Africa - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Chile - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Accelerating global shift precision oncology demanding multiplex biomarker analysis
  • Rapid decentralization clinical testing toward point care microfluidics
  • Pharmaceutical research and development pipeline expansion utilizing organ on chip platforms
• 13.2 Market challenges
  • High initial microfabrication cleanroom production costs restricting commercial accessibility
  • Biological surface functionalization inconsistencies causing batch reliability impairment
  • Complex interoperability gaps legacy diagnostic equipment impeding integration
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration semiconductor cmos sensors direct electronic biomarker signal detection
  • Implementation microfluidic continuous multiplex monitoring wearable patch biochips
  • Shift toward synthetic aptamers biorecognition probes enhancing chip stability

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 Aline Inc.
  • Aline Inc. - Overview
  • Aline Inc. - Product / Service
  • Aline Inc. - Key offerings
  • SWOT
• 15.7 BD Biosciences
  • BD Biosciences - Overview
  • BD Biosciences - Product / Service
  • BD Biosciences - Key offerings
  • SWOT
• 15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.9 Boao Bio Group Co. Ltd.
  • Boao Bio Group Co. Ltd. - Overview
  • Boao Bio Group Co. Ltd. - Product / Service
  • Boao Bio Group Co. Ltd. - Key offerings
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Macrogen Inc.
  • Macrogen Inc. - Overview
  • Macrogen Inc. - Product / Service
  • Macrogen Inc. - Key offerings
  • SWOT
• 15.12 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.13 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.14 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.15 Sony Biotechnology Inc.
  • Sony Biotechnology Inc. - Overview
  • Sony Biotechnology Inc. - Product / Service
  • Sony Biotechnology Inc. - Key offerings
  • SWOT
• 15.16 Takara Holdings Inc.
  • Takara Holdings Inc. - Overview
  • Takara Holdings Inc. - Business segments
  • Takara Holdings Inc. - Key offerings
  • Takara Holdings Inc. - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Toray Industries Inc.
  • Toray Industries Inc. - Overview
  • Toray Industries Inc. - Business segments
  • Toray Industries Inc. - Key news
  • Toray Industries Inc. - Key offerings
  • Toray Industries Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations